tiprankstipranks
HealthLynked Corp (HLYK)
OTHER OTC:HLYK
US Market

HealthLynked (HLYK) Income Statement

35 Followers

HealthLynked Income Statement

Last quarter (Q3 2023), HealthLynked's total revenue was $1.33M, a decrease of -7.96% from the same quarter last year. In Q3, HealthLynked's net income was $-174.92K. See HealthLynked’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 5.95M$ 5.86M$ 9.20M$ 6.13M$ 4.02M$ 2.26M
Cost of Revenue
$ -363.51K$ 339.87K-$ 1.16M--
Gross Profit
$ 2.91M$ 5.86M$ 1.01M$ 4.97M--
Operating Expense
$ -2.55M$ 14.52M$ -14.24M$ 8.04M$ 7.23M$ 5.23M
Operating Income
$ -848.54K$ -8.66M$ -13.23M$ -3.07M$ -3.21M$ -2.97M
Net Non Operating Interest Income Expense
$ -514.19K$ -110.00K$ -392.80K$ -780.69K$ -1.64M$ -2.18M
Other Income Expense
$ -4.01M$ 22.82K$ -3.21M$ -1.90M$ -679.46K$ -640.05K
Pretax Income
$ -5.85M$ -8.07M$ -10.41M$ -5.76M$ -5.53M$ -5.79M
Tax Provision
$ 214.10K$ -214.10K-$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 1.47M$ -9.17M$ -10.77M$ -6.20M$ -5.53M$ -5.79M
Basic EPS
$ 0.01$ -0.08$ -0.05$ -0.04$ -0.06$ -0.07
Diluted EPS
$ 0.01$ -0.08$ -0.05$ -0.04$ -0.06$ -0.07
Basic Average Shares
$ 1.03B$ 243.42M$ 227.85M$ 142.82M$ 99.06M$ 78.82M
Diluted Average Shares
$ 1.03B$ 243.42M$ 227.85M$ 142.82M$ 99.06M$ 78.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -2.91M$ 14.86M$ -14.24M$ 9.20M$ 7.23M$ 5.23M
Net Income From Continuing And Discontinued Operation
$ -4.00M$ -8.82M$ -10.41M$ -5.76M$ -5.53M$ -5.79M
Normalized Income
$ -588.84K$ -15.50M-$ -4.23M$ -4.97M$ -5.29M
Interest Expense
---$ 780.69K$ 1.50M$ 956.73K
EBIT
$ -5.34M$ -7.96M$ -10.02M$ -4.97M$ -4.02M$ -4.83M
EBITDA
$ -4.78M$ -7.07M$ -9.19M$ -4.73M$ -3.95M$ -4.81M
Currency in USD

HealthLynked Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis